Dengue Testing Market Research Report – Segmented By product type (ELISA-based Tests, Dengue IgG/IgM Rapid Test, RT-PCR based Tests and Others); By End User (Hospitals, Diagnostic Centres and Others); and Region - Size, Share, Growth Analysis | Forecast (2025 – 2030)
Dengue Testing Market Size (2025 – 2030)
The Dengue Testing Market was valued at USD 650 million in 2024. Over the forecast period of 2025-2030, it is projected to reach USD 849.52 billion by 2030, growing at a CAGR of 5.5%.
Dengue fever is a viral illness transmitted by mosquitoes, impacting individuals. The primary diagnostic methods for detecting the dengue virus include blood tests based on ELISA or PCR techniques. Recently developed rapid point-of-care tests enable the early identification and timely reporting of the disease.
Key Market Insights:
The growing prevalence of dengue cases is a key factor fueling the global demand for diagnostic kits.
The World Health Organization (WHO) reports a continuous increase in the number of dengue cases.
Additionally, technological innovations, enhanced healthcare services, advanced treatments, and government initiatives aimed at raising awareness are all contributing to the expansion opportunities for companies in this field.
Manufacturers are prioritizing the development of point-of-care diagnostic kits that are fast, accurate, and user-friendly. As a result, the increasing investment in research and development activities is further propelling the growth of the global dengue testing market.
Dengue Testing Market Drivers:
The annual increase in dengue fever cases is driving the growth of the market.
The growing prevalence of dengue fever, along with increasing awareness initiatives highlighting the disease's impact, is driving the global market for dengue virus diagnostic testing. In recent years, dengue cases have surged significantly. The primary regions affected by dengue include Africa, the Americas, the Eastern Mediterranean, Southeast Asia, and the Western Pacific. Of the reported cases, approximately 500,000 progress to dengue hemorrhagic fever or severe dengue, a more critical form of the disease that results in up to 25,000 deaths annually worldwide.
The demand for affordable test kits with high specificity and sensitivity is rising due to the lack of effective diagnostic tools and the high cost of existing testing solutions. Consequently, companies in the market are focusing on developing cost-effective and reliable dengue diagnostic technologies. Climate change is expected to further increase the incidence of dengue fever, thereby accelerating the growth of the dengue testing market. Despite heightened awareness regarding prevention and treatment, several challenges persist, including insufficient funding and resources, as well as the absence of a clear strategy to tackle the growing challenges posed by dengue outbreaks in various regions. Factors such as rapid urbanization, inadequate sanitation, increased international trade, and population mobility complicate efforts to mitigate the spread of the disease.
The rise in awareness campaigns aimed at educating the public about the dangers of dengue is contributing to the growth of the market. Governments and healthcare organizations worldwide acknowledge the critical role of public awareness in combating dengue. Public health campaigns are designed to educate communities on preventive measures, such as eliminating mosquito breeding sites. These initiatives also emphasize the importance of identifying early symptoms and seeking timely medical care, while fostering community involvement in the effort to fight dengue.
Dengue Testing Market Restraints and Challenges:
The limited availability of testing facilities in remote areas poses a significant barrier to the growth of the market.
The market encounters several challenges, including restricted access to healthcare in remote regions, the high cost of advanced testing kits, and inconsistencies in test accuracy. Additionally, regulatory obstacles and the requirement for skilled professionals complicate the expansion of the market.
Dengue Testing Market Opportunities:
Technological advancements in diagnostic tools present significant opportunities for growth in the market.
Emerging technological advancements have significantly improved the diagnosis of dengue, driving market growth. In particular, point-of-care testing (POCT) offers rapid and more accurate diagnoses in the field of dengue treatment. POCT devices deliver key advantages by providing immediate diagnostic results, which are especially valuable in regions with limited healthcare infrastructure. These tests are quick and convenient, enabling faster decision-making in clinical settings and improving response times during outbreaks. As these technologies continue to evolve, they are becoming more user-friendly and affordable, further promoting their adoption into mainstream healthcare practices worldwide. This trend not only enhances patient care but also plays a crucial role in controlling and reducing disease spread by facilitating timely interventions.
Strategic imperatives are creating valuable opportunities in the market.
To capitalize on regional growth potential, companies must implement localization strategies. Developing diagnostic tests tailored to specific regional dengue strains and aligning with local healthcare systems is essential. Collaborating with local governments, healthcare providers, and partnering with wholesale dengue detection test manufacturers are critical for successful market penetration. Furthermore, the rise of other vector-borne diseases could divert resources, requiring dengue test manufacturers to adopt flexible and adaptable strategies to maintain market relevance.
DENGUE TESTING MARKET REPORT COVERAGE:
REPORT METRIC
DETAILS
Market Size Available
2024 - 2030
Base Year
2024
Forecast Period
2025 - 2030
CAGR
5.5%
Segments Covered
By Product type, End User, and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
Regional Scope
North America, Europe, APAC, Latin America, Middle East & Africa
Key Companies Profile
Thermo Fisher Scientific Inc., Abbott Laboratories, Roche Molecular Systems Inc. , Abnova Corporation, NovaTec Immundiagnostica GmbH , InBios International, Inc., Euroimmun AG (Sub. PerkinElmer), QuantuMDx Group Ltd, Ceres Nanosciences Inc. , OriGene Technologies
Dengue Testing Market Segmentation: By product type
ELISA-based Tests
Dengue IgG/IgM Rapid Test
RT-PCR based Tests
Others
The ELISA-based segment is anticipated to hold the largest market share throughout the forecast period. The enzyme-linked immunosorbent assay (ELISA), which detects anti-DENV IgM or IgG antibodies in patient serum, remains the most widely used method for diagnosing dengue fever. Early detection and treatment of dengue help reduce morbidity and mortality associated with severe forms of the disease, as well as mitigate the risk of widespread outbreaks. In 2023, the EIA/ELISA category led the immunoassay market, capturing a revenue share of 63.7%. The key advantages of this technology over immunoelectrophoresis and immunodiffusion include reduced test times, quantitative results, and the use of smaller amounts of antisera for analysis.
Meanwhile, RT-PCR testing is expected to experience significant growth. For instance, in April 2022, Beroni Group Limited and Columbia University signed an exclusive licensing agreement, granting Beroni and its affiliates worldwide distribution rights for the patented CII-ArboViroPlex rRT-PCR assay.
Dengue Testing Market Segmentation: By End User
Hospitals
Diagnostic Centres
Others
The ELISA-based segment is projected to maintain a dominant market share throughout the forecast period. The enzyme-linked immunosorbent assay (ELISA), which detects anti-DENV IgM or IgG antibodies in patient serum, is the most widely utilized method for diagnosing dengue fever. Early detection and timely treatment of dengue fever help reduce morbidity and mortality rates associated with severe forms of the disease and minimize the risk of large-scale outbreaks. In 2023, the EIA/ELISA category led the immunoassay market, capturing a revenue share of 63.7%. The technology’s advantages over immunoelectrophoresis and immunodiffusion include faster test times, quantitative results, and the need for smaller amounts of antisera for analysis.
Dengue Testing Market Segmentation- by region
North America
Europe
Asia Pacific
South America
Middle East & Africa
The Asia Pacific region is expected to lead the global dengue testing market. Dengue fever is most prevalent in Southeast Asia, with the disease continuing to rise. The increasing incidence of infectious diseases, particularly dengue fever, in countries like India, Pakistan, and Sri Lanka, is driving rapid market growth in this region. In the Americas, there were 3.1 million reported cases, with over 25,000 classified as severe. Despite the high number of infections, dengue-related mortality has decreased compared to the previous year.
In Latin America, the market is also experiencing rapid growth due to the rising incidence of dengue fever and government initiatives aimed at improving healthcare infrastructure.
COVID-19 Pandemic: Impact Analysis
The COVID-19 pandemic and subsequent lockdowns led to the closure of airports, ports, and both commercial and domestic transportation in many countries. This had a significant impact on manufacturing activities and operations globally, severely affecting the economies of various nations. The outbreak, along with social distancing measures and restrictions, disrupted business operations and the overall business environment worldwide. The sudden and substantial decline in economic activity resulted in slowdowns across manufacturing, production, agriculture, fisheries, dairy, and other sectors, causing widespread job losses. Supply chain disruptions were further exacerbated by demand-side challenges, including reduced disposable income, dwindling savings, and growing concerns and uncertainties.
Latest Trends/ Developments:
In August 2024, J Mitra & Company launched the Dengue NS1 Antigen self-test kit, marking a first for home use in India. This innovative kit allows individuals to perform the test independently at any location and provides results within 20 minutes through a rapid visual test, simplifying the interpretation of results. The kit is highly sensitive and accurate, capable of detecting all four dengue virus serotypes. Classified as a Point of Care Test (POCT), it is designed for ease of use, requiring no specialized training. The testing process involves placing a drop of blood into the sample well, adding a drop of assay buffer, and receiving results in just 20 minutes.
On September 12, 2024, QIAGEN announced the expansion of its strategic partnership with Bio-Manguinhos/Fiocruz, the primary provider of vaccines and diagnostics for Brazil's Ministry of Health. This expanded collaboration allows Bio-Manguinhos to introduce a sophisticated PCR-based molecular screening platform that detects malaria, HIV, and hepatitis B and C (HBV and HCV). Additionally, this partnership supports Brazil's efforts in monitoring dengue fever by implementing dengue molecular kits, developed with exclusive chemistry created by QIAGEN and Bio-Manguinhos/Fiocruz. QIAGEN will provide essential molecular biology technologies, tailored solutions, and comprehensive training to strengthen Brazil's public health initiatives.
In August 2023, Mylab Discovery Solutions launched two rapid point-of-care dengue tests: the rapid gold test and the high-accuracy dry luminescence assay test. These tests, which provide results in 15-20 minutes, are capable of identifying the stage and progression of dengue infections without the need for laboratory facilities. They are particularly beneficial in resource-limited settings, aiding in dengue screening efforts.
Key Players:
These are top 10 players in the Dengue Testing Market :-
Thermo Fisher Scientific Inc.
Abbott Laboratories
Roche Molecular Systems Inc.
Abnova Corporation
NovaTec Immundiagnostica GmbH
InBios International, Inc.
Euroimmun AG (Sub. PerkinElmer)
QuantuMDx Group Ltd
Ceres Nanosciences Inc.
OriGene Technologies
To Learn more about this report,
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Key Market Insights:
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
Global Automotive Lighting Market Drivers:
Using cutting-edge technology to illuminate the road, safety serves as a guiding light.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Beyond Performance-Based Luxuries Redefined by Light.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
Fuel Efficiency Takes the Lead: Illuminating Sustainability
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
To Learn more about this report,
Global Automotive Lighting Market Restraints and Challenges:
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
Global Automotive Lighting Market Opportunities:
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
AUTOMOTIVE LIGHTING MARKET REPORT COVERAGE:
To Learn more about this report,
Global Automotive Lighting Market Segmentation: By Application
Exterior Lighting
Interior Lighting
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
Global Automotive Lighting Market Segmentation: By Technology
Halogen
LED (Light-Emitting Diode)
Xenon
Emerging Technologies
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Global Automotive Lighting Market Segmentation: By Vehicle Type
Passenger Cars
Commercial Vehicles
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Global Automotive Lighting Market Segmentation: By Sales Channel
OEM (Original Equipment Manufacturers)
Aftermarket
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
To Learn more about this report,
Global Automotive Lighting Market Segmentation: By Region
North America
Asia-Pacific
Europe
South America
Middle East and Africa
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
COVID-19 Impact Analysis on the Global Automotive Lighting Market:
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
Recent Trends and Developments in the Global Automotive Lighting Market:
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
Key Players:
AMS Osram
Cree
Hella
Hyundai Mobis
Koito
Luminus Devices
Magneti Marelli
Osram Licht AG
Stanley Electric
Valeo
Chapter 1. Dengue Testing Market – Scope & Methodology
1.1 Market Segmentation
1.2 Scope, Assumptions & Limitations
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources Chapter 2. Dengue Testing Market – Executive Summary
2.1 Market Size & Forecast – (2025 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.2.1 Demand Side
2.2.2 Supply Side
2.3 Attractive Investment Propositions
2.4 COVID-19 Impact Analysis Chapter 3. Dengue Testing Market – Competition Scenario
3.1 Market Share Analysis & Company Benchmarking
3.2 Competitive Strategy & Development Scenario
3.3 Competitive Pricing Analysis
3.4 Supplier-Distributor Analysis Chapter 4. Dengue Testing Market - Entry Scenario
4.1 Regulatory Scenario
4.2 Case Studies – Key Start-ups
4.3 Customer Analysis
4.4 PESTLE Analysis
4.5 Porters Five Force Model
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Powers of Customers
4.5.3 Threat of New Entrants
4.5.4 Rivalry among Existing Players
4.5.5 Threat of Substitutes Chapter 5. Dengue Testing Market – Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities Chapter 6. Dengue Testing Market – By Product Type
6.1 Introduction/Key Findings
6.2 ELISA-based Tests
6.3 Dengue IgG/IgM Rapid Test
6.4 RT-PCR based Tests
6.5 Others
6.6 Y-O-Y Growth trend Analysis By Product Type
6.7 Absolute $ Opportunity Analysis By Product Type, 2025-2030 Chapter 7. Dengue Testing Market – By End User
7.1 Introduction/Key Findings
7.2 Hospitals
7.3 Diagnostic Centres
7.4 Others
7.5 Y-O-Y Growth trend Analysis By End User
7.6 Absolute $ Opportunity Analysis By End User, 2025-2030 Chapter 8. Dengue Testing Market , By Geography – Market Size, Forecast, Trends & Insights
8.1 North America
8.1.1 By Country
8.1.1.1 U.S.A.
8.1.1.2 Canada
8.1.1.3 Mexico
8.1.2 By Product Type
8.1.3 By End User
8.1.4 Countries & Segments - Market Attractiveness Analysis
8.2 Europe
8.2.1 By Country
8.2.1.1 U.K
8.2.1.2 Germany
8.2.1.3 France
8.2.1.4 Italy
8.2.1.5 Spain
8.2.1.6 Rest of Europe
8.2.2 By Product Type
8.2.3 By End User
8.2.4 Countries & Segments - Market Attractiveness Analysis
8.3 Asia Pacific
8.3.1 By Country
8.3.1.1 China
8.3.1.2 Japan
8.3.1.3 South Korea
8.3.1.4 India
8.3.1.5 Australia & New Zealand
8.3.1.6 Rest of Asia-Pacific
8.3.2 By Product Type
8.3.3 By End User
8.3.4 Countries & Segments - Market Attractiveness Analysis
8.4 South America
8.4.1 By Country
8.4.1.1 Brazil
8.4.1.2 Argentina
8.4.1.3 Colombia
8.4.1.4 Chile
8.4.1.5 Rest of South America
8.4.2 By Product Type
8.4.3 By End User
8.4.4 Countries & Segments - Market Attractiveness Analysis
8.5 Middle East & Africa
8.5.1 By Country
8.5.1.1 United Arab Emirates (UAE)
8.5.1.2 Saudi Arabia
8.5.1.3 Qatar
8.5.1.4 Israel
8.5.1.5 South Africa
8.5.1.6 Nigeria
8.5.1.7 Kenya
8.5.1.8 Egypt
8.5.1.9 Rest of MEA
8.5.2 By Product Type
8.5.3 By End User
8.5.4 Countries & Segments - Market Attractiveness Analysis Chapter 9. Dengue Testing Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
9.1 Thermo Fisher Scientific Inc.
9.2 Abbott Laboratories
9.3 Roche Molecular Systems Inc.
9.4 Abnova Corporation
9.5 NovaTec Immundiagnostica GmbH
9.6 InBios International, Inc.
9.7 Euroimmun AG (Sub. PerkinElmer)
9.8 QuantuMDx Group Ltd
9.9 Ceres Nanosciences Inc.
9.10 OriGene Technologies
Fill out the form below and our team will get back to you shortly
FAQ's
The growing prevalence of dengue cases is a key factor fueling the global demand for diagnostic kits. The World Health Organization (WHO) reports a continuous increase in the number of dengue cases.
The top players operating in the Dengue Testing Market are - Thermo Fisher Scientific Inc., Abbott Laboratories, Roche Molecular Systems Inc., Abnova Corporation and NovaTec Immundiagnostica GmbH.
The COVID-19 pandemic and subsequent lockdowns led to the closure of airports, ports, and both commercial and domestic transportation in many countries.
Emerging technological advancements have significantly improved the diagnosis of dengue, driving market growth. In particular, point-of-care testing (POCT) offers rapid and more accurate diagnoses in the field of dengue treatment.
Latin America is the fastest-growing region in the Dengue Testing Market.
More related reports
Get expert-driven market research reports from a leading research partner to help you navigate the future of the global industry.
Report Code: VMR-19361 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Newborn Screening Market was valued at approximately USD 6.14 Billion. It is projected to grow at a CAGR of around 7.6% during the forecast period of 2026–2030, reaching an estimated USD 8.86 Billion by 2030...
Report Code: VMR-19360 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Home Diagnostics & Self-Testing Market was valued at approximately USD 9.85 Billion. It is projected to grow at a CAGR of around 7.9% during the forecast period of 2026–2030, reaching an estimated USD 14.41...
Report Code: VMR-19359 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Home Diagnostics & Self-Testing Market was valued at approximately USD 9.85 Billion. It is projected to grow at a CAGR of around 7.9% during the forecast period of 2026–2030, reaching an estimated USD 14.41...
Report Code: VMR-19358 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Clinical Microbiology Testing Market was valued at approximately USD 9.85 Billion. It is projected to grow at a CAGR of around 7.9% during the forecast period of 2026–2030, reaching an estimated USD 14.41 Bi...
Report Code: VMR-19356 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Global Fertility Services & IVF Technology Market was valued at approximately USD 53 Billion and is projected to reach around USD 82.30 Billion by 2030, expanding at a CAGR of about 9.2% during 2026–2030.
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”